About us

About Us

Biogege was founded in 2023 and is a high-tech enterprise focused on gene technology research and application transformation, located in Wuhan. Biogege has always been committed to the research and production of gene vectors, and our core competitive products include lentiviruses, adenoviruses, adeno-associated viruses, plasmids, and KO cell lines.

At the same time, we focus on hot topics, including autophagy flow research tools, virus vector-based CRISPR gene editing tools, non-coding RNA, and luciferase experiments. Our independently developed autophagy LC3 double-labeled adenovirus is recognized as a gold-standard research tool in the field of autophagy.

In the future, we will focus more on the application of core gene technology in clinical transformation.

Biogege, Better Gene Technology.